132 related articles for article (PubMed ID: 21789698)
21. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
[TBL] [Abstract][Full Text] [Related]
22. The association of hydrocephalus with intramedullary spinal cord tumors: a series of 25 patients.
Rifkinson-Mann S; Wisoff JH; Epstein F
Neurosurgery; 1990 Nov; 27(5):749-54; discussion 754. PubMed ID: 2175400
[TBL] [Abstract][Full Text] [Related]
23. Surgical pathology of intramedullary spinal cord neoplasms.
Miller DC
J Neurooncol; 2000 May; 47(3):189-94. PubMed ID: 11016735
[TBL] [Abstract][Full Text] [Related]
24. Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.
Lehtinen B; Raita A; Kesseli J; Annala M; Nordfors K; Yli-Harja O; Zhang W; Visakorpi T; Nykter M; Haapasalo H; Granberg KJ
BMC Cancer; 2017 May; 17(1):310. PubMed ID: 28468611
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcomes of patients with spinal cord gliomas treated by modern conformal radiation techniques.
Kahn J; Loeffler JS; Niemierko A; Chiocca EA; Batchelor T; Chakravarti A
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):232-8. PubMed ID: 20947265
[TBL] [Abstract][Full Text] [Related]
26. Genomic Landscape of Intramedullary Spinal Cord Gliomas.
Zhang M; Iyer RR; Azad TD; Wang Q; Garzon-Muvdi T; Wang J; Liu A; Burger P; Eberhart C; Rodriguez FJ; Sciubba DM; Wolinsky JP; Gokaslan Z; Groves ML; Jallo GI; Bettegowda C
Sci Rep; 2019 Dec; 9(1):18722. PubMed ID: 31822682
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors and survival in patients with spinal cord gliomas after radiation therapy.
Abdel-Wahab M; Corn B; Wolfson A; Raub W; Gaspar LE; Curran W; Bustillo P; Rubinton P; Markoe A
Am J Clin Oncol; 1999 Aug; 22(4):344-51. PubMed ID: 10440187
[TBL] [Abstract][Full Text] [Related]
28. Low-grade spinal glioneuronal tumors with BRAF gene fusion and 1p deletion but without leptomeningeal dissemination.
Chiang JCH; Harreld JH; Orr BA; Sharma S; Ismail A; Segura AD; Ellison DW
Acta Neuropathol; 2017 Jul; 134(1):159-162. PubMed ID: 28547128
[No Abstract] [Full Text] [Related]
29. Intramedullary spinal cord astrocytoma versus glioblastoma: the prognostic importance of histologic grade.
Kopelson G; Linggood RM
Cancer; 1982 Aug; 50(4):732-5. PubMed ID: 7093908
[No Abstract] [Full Text] [Related]
30. Comparative genomic and proteomic analysis of high grade glioma primary cultures and matched tumor in situ.
Howley R; Kinsella P; Buckley PG; Alcock L; Jansen M; Heffernan J; Stallings RL; Brett FM; Amberger-Murphy V; Farrell MA
Exp Cell Res; 2012 Oct; 318(17):2245-56. PubMed ID: 22705586
[TBL] [Abstract][Full Text] [Related]
31. Leptomeningeal spread of intramedullary spinal cord tumors. Report of three cases.
Bell WO; Packer RJ; Seigel KR; Rorke LB; Sutton LN; Bruce DA; Schut L
J Neurosurg; 1988 Aug; 69(2):295-300. PubMed ID: 3392575
[TBL] [Abstract][Full Text] [Related]
32. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
Zhou YX; Wang JX; Feng M; Sun CM; Sun T; Chen GL; Du ZW
J Mol Neurosci; 2012 Jul; 47(3):442-7. PubMed ID: 22113362
[TBL] [Abstract][Full Text] [Related]
33. Intramedullary spinal cord ependymoma and astrocytoma: intraoperative frozen-section diagnosis, extent of resection, and outcomes.
Hongo H; Takai K; Komori T; Taniguchi M
J Neurosurg Spine; 2018 Oct; 30(1):133-139. PubMed ID: 30485241
[TBL] [Abstract][Full Text] [Related]
34. Recurrence rates and functional outcome after resection of intrinsic intramedullary tumors.
Schebesch KM; Mueller S; Wendl C; Brawanski A; Riemenschneider MJ; Proescholdt M
Clin Neurol Neurosurg; 2015 Jul; 134():60-6. PubMed ID: 25950925
[TBL] [Abstract][Full Text] [Related]
35. The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation.
Chai RC; Zhang YW; Liu YQ; Chang YZ; Pang B; Jiang T; Jia WQ; Wang YZ
Acta Neuropathol Commun; 2020 Mar; 8(1):40. PubMed ID: 32228694
[TBL] [Abstract][Full Text] [Related]
36. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms.
Henriksen R; Funa K; Wilander E; Bäckström T; Ridderheim M; Oberg K
Cancer Res; 1993 Oct; 53(19):4550-4. PubMed ID: 8402626
[TBL] [Abstract][Full Text] [Related]
37. Changing incidence and improved survival of gliomas.
Ho VK; Reijneveld JC; Enting RH; Bienfait HP; Robe P; Baumert BG; Visser O;
Eur J Cancer; 2014 Sep; 50(13):2309-18. PubMed ID: 24972545
[TBL] [Abstract][Full Text] [Related]
38. Growth factor profiles of human gliomas. Do non-tumour cells contribute to tumour growth in glioma?
van der Valk P; Lindeman J; Kamphorst W
Ann Oncol; 1997 Oct; 8(10):1023-9. PubMed ID: 9402177
[TBL] [Abstract][Full Text] [Related]
39. Involvement of CD9 and PDGFR in migration is evolutionarily conserved from Drosophila glia to human glioma.
Jeibmann A; Halama K; Witte HT; Kim SN; Eikmeier K; Koos B; Klämbt C; Paulus W
J Neurooncol; 2015 Sep; 124(3):373-83. PubMed ID: 26224160
[TBL] [Abstract][Full Text] [Related]
40. GM1 inhibits early signaling events mediated by PDGF receptor in cultured human glioma cells.
Farooqui T; Kelley T; Coggeshall KM; Rampersaud AA; Yates AJ
Anticancer Res; 1999; 19(6B):5007-13. PubMed ID: 10697503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
